Report

Global Liver Disease Diagnostics Market Size study, by Diagnosis Technique (Laboratory Tests, Imaging, Endoscopy, Biopsy and Others), by End-Use (Hospitals, Laboratories and Others) and Regional Forecasts 2020-2027

  • Publish Date: Mar,2022
  • Report ID: QI037
  • Page : 250
  • Report Type : PDF (Email)
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
1.2.1. Liver Disease Diagnostics Market, by Region, 2018-2027 (USD Billion)
1.2.2. Liver Disease Diagnostics Market, by Diagnosis Technique, 2018-2027 (USD Billion)
1.2.3. Liver Disease Diagnostics Market, by End-Use, 2018-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Liver Disease Diagnostics Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Liver Disease Diagnostics Market Dynamics
3.1. Liver Disease Diagnostics Market Impact Analysis (2018-2027)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Liver Disease Diagnostics Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model (2017-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Liver Disease Diagnostics Market, by Diagnosis Technique
5.1. Market Snapshot
5.2. Global Liver Disease Diagnostics Market by Diagnosis Technique, Performance - Potential Analysis
5.3. Global Liver Disease Diagnostics Market Estimates & Forecasts by Diagnosis Technique 2017-2027 (USD Billion)
5.4. Liver Disease Diagnostics Market, Sub Segment Analysis
5.4.1. Laboratory Tests
5.4.2. Imaging
5.4.3. Endoscopy
5.4.4. Biopsy
5.4.5. Others
Chapter 6. Global Liver Disease Diagnostics Market, by End-Use
6.1. Market Snapshot
6.2. Global Liver Disease Diagnostics Market by End-Use, Performance - Potential Analysis
6.3. Global Liver Disease Diagnostics Market Estimates & Forecasts by End-Use 2017-2027 (USD Billion)
6.4. Liver Disease Diagnostics Market, Sub Segment Analysis
6.4.1. Hospitals
6.4.2. Laboratories
6.4.3. Others
Chapter 7. Global Liver Disease Diagnostics Market, Regional Analysis
7.1. Liver Disease Diagnostics Market, Regional Market Snapshot
7.2. North America Liver Disease Diagnostics Market
7.2.1. U.S. Liver Disease Diagnostics Market
7.2.1.1. Diagnosis Technique breakdown estimates & forecasts, 2017-2027
7.2.1.2. End-Use breakdown estimates & forecasts, 2017-2027
7.2.2. Canada Liver Disease Diagnostics Market
7.3. Europe Liver Disease Diagnostics Market Snapshot
7.3.1. U.K. Liver Disease Diagnostics Market
7.3.2. Germany Liver Disease Diagnostics Market
7.3.3. France Liver Disease Diagnostics Market
7.3.4. Spain Liver Disease Diagnostics Market
7.3.5. Italy Liver Disease Diagnostics Market
7.3.6. Rest of Europe Liver Disease Diagnostics Market
7.4. Asia-Pacific Liver Disease Diagnostics Market Snapshot
7.4.1. China Liver Disease Diagnostics Market
7.4.2. India Liver Disease Diagnostics Market
7.4.3. Japan Liver Disease Diagnostics Market
7.4.4. Australia Liver Disease Diagnostics Market
7.4.5. South Korea Liver Disease Diagnostics Market
7.4.6. Rest of Asia Pacific Liver Disease Diagnostics Market
7.5. Latin America Liver Disease Diagnostics Market Snapshot
7.5.1. Brazil Liver Disease Diagnostics Market
7.5.2. Mexico Liver Disease Diagnostics Market
7.6. Rest of The World Liver Disease Diagnostics Market

Chapter 8. Competitive Intelligence
8.1. Top Market Strategies
8.2. Company Profiles
8.2.1. Abbott Laboratories
8.2.1.1. Key Information
8.2.1.2. Overview
8.2.1.3. Financial (Subject to Data Availability)
8.2.1.4. Product Summary
8.2.1.5. Recent Developments
8.2.2. F.Hoffmann-La Roche AG
8.2.3. Randox Laboratories
8.2.4. Boston Scientific Corporation
8.2.5. Siemens Healthineers AG
8.2.6. BioMerieux
8.2.7. Quest Diagnostics
8.2.8. Biosino Bio-technology
8.2.9. Horiba, Ltd.
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption